2024-517756-35-00RecruitingPhase 1
A study to learn about the study medicine called PF-08046032 in people with advanced cancers.
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Pfizer Inc.
- Enrollment
- 33
- Locations
- 3
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Clinical Medical Lead
Scientific
Pfizer Inc.
Study Sites (3)
Loading locations...
Similar Trials
Recruiting
Not Applicable
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaAsthmajRCT2031250163Pfizer Japan Inc.252
Recruiting
Not Applicable
A Study to Learn About the Study Medicine Called PF-07868489 in People With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionjRCT2051240229Pfizer Japan Inc.90
Active, not recruiting
Not Applicable
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of TreatmentjRCT2051230196Pfizer Japan Inc.510
Recruiting
Not Applicable
A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease (EPIC-Peds)jRCT2031250096Pfizer Japan Inc.160
Not yet recruiting
Not Applicable
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) (BRANCH-HF)jRCT2031250168Pfizer Japan Inc.620